ZINZINO AB (PUBL.): Preliminary sales report November 2025
Zinzino group revenue increased with a total of 45 %, compared with the previous year.
The revenue in November for Zinzino's sales markets increased by 49 % and amounted to SEK 375.0 (251.8) million. Faun Pharma's external sales decreased and amounted to SEK 4.3 (10.1) million. Overall, the Group increased revenues by 45 % to SEK 379.3 (261.9) million compared with the previous year.
Accumulated revenue for January – November 2025 increased by 54 % to SEK 3,007.5 (1,955.1) million.
Revenues were distributed as follows:
|
Regions,MSEK |
25-Nov |
24-Nov |
Change |
YTD 2025 |
YTD 2024 |
Change |
|
The Nordics |
29.7 |
29.0 |
2% |
301.0 |
272.3 |
11% |
|
Central Europe |
133.9 |
70.4 |
90% |
892.2 |
518.7 |
72% |
|
East Europe |
51.5 |
51.6 |
0% |
361.9 |
366.0 |
-1% |
|
South & West Europe |
58.7 |
45.3 |
30% |
513.9 |
346.7 |
48% |
|
The Baltics |
17.3 |
16.1 |
7% |
115.4 |
95.6 |
21% |
|
North America |
58.1 |
25.8 |
125% |
491.0 |
179.2 |
174% |
|
Asia-Pacific |
23.0 |
11.1 |
107% |
263.7 |
64.4 |
309% |
|
Africa |
2.8 |
2.5 |
12% |
21.1 |
15.1 |
40% |
|
Zinzino |
375.0 |
251.8 |
49% |
2960.2 |
1858.0 |
59% |
|
Faun Pharma |
4.3 |
10.1 |
-57% |
47.3 |
97.1 |
-51% |
|
Zinzino Group |
379.3 |
261.9 |
45% |
3007.5 |
1955.1 |
54% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: DNB Carnegie Investment Bank AB (publ.)
Zinzino is a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company’s test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino’s headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.